Peru vs Saint Kitts and Nevis: Hypertension effective treatment coverage (controlled hypertension)
Peru
21.7%
in 2019
Saint Kitts and Nevis
22.3%
in 2019
Peru rank
73rd
Saint Kitts and Nevis rank
70th
Hypertension effective treatment coverage (controlled hypertension) over time
- Peru
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 22.3% against 21.7% in Peru, a difference of 0.6%.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Saint Kitts and Nevis ahead.
Peru ranks 73rd and Saint Kitts and Nevis ranks 70th of 193 countries.
Across the 3 decades both report, Peru averaged higher in 1 and Saint Kitts and Nevis in 2.
Head to head by decade
| Decade | Peru | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.6% | 7.6% | 1.0% | Saint Kitts and Nevis |
| 2000s | 13.3% | 14.1% | 0.8% | Saint Kitts and Nevis |
| 2010s | 21.5% | 20.7% | 0.8% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Peru or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 22.3% against 21.7% in Peru as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Peru and Saint Kitts and Nevis?
- 0.6%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Peru and Saint Kitts and Nevis?
- 30 years are reported by both, from 1990 to 2019.
- How do Peru and Saint Kitts and Nevis rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Peru ranks 73rd and Saint Kitts and Nevis ranks 70th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.